Condition: Syndrome · Sponsor: Riphah International University
The study design would be a Randomized Controlled Trial.This study would include a total 40 participants. 20 participants in each group. Sample size is obtained through G-power. The study duration will be 12 months after the approval from the research board. Non-probability convenience sampling will be used. Randomization will be done through sealed envelope method. The study will be conducted from Quaid-e-Azam Hospital Rawalpindi and Margalla Rehabilitation Centre.
This description comes directly from the study's public registry record.
REHMAT KHATOON, MS-OMPT · 0321-8562693 · rehmi123jillani@gmail.com
Attiq ur Rehman Physiotherapist, MS · +92-336-1055533 · attiq.rehman@riphah.edu.pk
Always discuss trial participation with your own doctor first.
| Riphah University Islamabad | Islamabad, Pakistan | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07576114